Uncommon causes of hemoglobin E flags identified during measurement of hemoglobin A1c by ion-exchange high-performance liquid chromatography

被引:0
作者
Herb, Thomas [1 ]
Taylor, Alexander S. [1 ]
Li, Shih-Hon [1 ]
Manthei, David M. [1 ]
Gherasim, Carmen [1 ]
机构
[1] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA
关键词
hemoglobin Hoshida; hemoglobin E; hemoglobin A1c; interference; hemoglobin variant; HPLC; clinical chemistry; VARIANTS; MANAGEMENT; VALUES; ASSAYS;
D O I
10.1093/labmed/lmad113
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
We present 3 cases of discordant results from screening hemoglobin A1c (HbA1c) measured by ion-exchange high-performance liquid chromatography (HPLC) all due to various forms of interference and flagged by the instrument as "suspected hemoglobin E (HbE)." The first case was due to a rare hemoglobin variant, later confirmed to be hemoglobin Hoshida, the second due to "true" heterozygous HbE, and the third a result of analytical artifact causing splitting of the HbA1c peak without an underlying variant hemoglobin. We examine the similarities in these cases along with the laboratory work-up to classify each cause of interference to demonstrate the wide array of potential causes for the suspected HbE flag and why it warrants proper work-up. Because there is no standardized method of reporting out hemoglobin variant interference in HbA1c measurement, we discuss our laboratory's process of investigating discordant HbA1c measurements and reporting results in cases with variant interference as 1 possible model to follow, along with discussing the associated laboratory, ethical, and clinical considerations. We also examine the structure of hemoglobin Hoshida, HbE, and conduct a brief literature review of previous reports.
引用
收藏
页码:528 / 533
页数:6
相关论文
共 20 条
  • [1] Beltran Del Rio Manuel, 2016, J Diabetes Sci Technol, V10, P1303
  • [2] Bry L, 2001, CLIN CHEM, V47, P153
  • [3] Bunn HF., 1984, Hemoglobin: molecular, genetic and clinical aspects
  • [4] Glycemic Targets: Standards of Medical Care in Diabetes-2019
    Cefalu, William T.
    Berg, Erika Gebel
    Saraco, Mindy
    Petersen, Matthew P.
    Uelmen, Sacha
    Robinson, Shamera
    [J]. DIABETES CARE, 2019, 42 : S61 - S70
  • [5] The Hemoglobin E Thalassemias
    Fucharoen, Suthat
    Weatherall, David J.
    [J]. COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (08):
  • [6] Tests of glycemia in diabetes
    Goldstein, DE
    Little, RR
    Lorenz, RA
    Malone, JI
    Nathan, D
    Peterson, CM
    Sacks, DB
    [J]. DIABETES CARE, 2004, 27 (07) : 1761 - 1773
  • [7] Hanley T., 2023, ADLM FORMERLY AACC
  • [8] HEMOGLOBIN HOSHIDA (BETA-43 (CD-2) GLU-]GLN), A NEW HEMOGLOBIN VARIANT DISCOVERED IN JAPAN
    IUCHI, I
    UEDA, S
    HIDAKA, K
    SHIBATA, S
    [J]. HEMOGLOBIN, 1978, 2 (03) : 235 - 247
  • [9] Establishment of a combined strategy of genetic and mass spectrometric analyses for characterizing hemoglobin mutations -: An example of Hb Hoshida (β43Glu→Gln)
    Kaneko, R
    Wada, Y
    Hisada, M
    Naoki, H
    Matsuo, T
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1999, 731 (01): : 125 - 130
  • [10] Management of Hemoglobin Variants Detected Incidentally in HbA1c Testing: A Common Problem Currently Lacking a Standard Approach
    Lewis, Michael R.
    Macauley, Robert C.
    Sheehan, Patricia R.
    Staten, Myrlene A.
    Phillips, Lawrence S.
    Rasouli, Neda
    Pittas, Anastassios G.
    [J]. DIABETES CARE, 2017, 40 (02) : E8 - E9